Name Of Patient : Mrs. SARITA Reg.

No : 0012601310166
Age/Gender : 38 Years/Female Collected On : 31-Jan-2026 02:13 PM
Referred By : Dr. SELF Received On : 31-Jan-2026 04:14 PM
Sample Type/ID : EDTA/818766 Reported On : 31-Jan-2026 04:23 PM
Client Panel : DL462-HEALTH X PLUS LABS- Report Status : Final Report
Referred By Lab : Self

HAEMATOLOGY
Test Name Results Unit [Link]

CBC, Complete Blood Count

HB Haemoglobin 12.0 gm/dL 11.5-15.5
Method Name: Photometry
RBC Red Blood Cell Count 4.4 millions/cumm 4.50-5.50
Method Name: Impedance
PCV Packed cell volume 34.50 % 30.0-55.0
Method Name: Calculated
MCV Mean Corpuscular Volume 79.4 fL 70.0-101.0
Method Name: Calculated
MCH Mean Corpuscular Hemoglobin 27.5 pg 27-32
Method Name: Calculated
MCHC Mean Corpuscular Hb Concentration 34.70 g/dL 30.0-36.0
Method Name: Calculated
RDW CV Red Cell Distribution Width 16.6 % 12.0-14.0
Method Name: By Automated/Calculated
RDW SD Red Cell Distribution Width 43.5 fL 35.0- 46.0
Method Name: Calculated
Platelet Count 161 10^3/µL 150-410
Method Name: Impedance
PCT Plateletcrit 0.20 % 0.12-0.40
Method Name: By Calculated
MPV Mean Platelet Volume 12.20 fL 7.10-12.50
Method Name: Plt Histogram
PDW Platelet Distribution Width 21.00 fL 8.30-18.0
Method Name: Calculated
PLCC Platelet Large Cell Coefficient 83.00 10^3/µL 45-95
Method Name: Calculated
PLCR Platelet Large Cell Ratio 51.70 % 11-45

TLC Total Leucocyte Count 10.7 10^3/µL 4.50-11.00

Method Name: Impedance /manual
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophil 70.00 % 40.0-80.0
Method Name: Impedance & absorbance/manual
Lymphocytes 20.00 % 20.0-40.0
Method Name: Impedance & absorbance/manual
Eosinophil 5.00 % 1.0-6.0
Method Name: Impedance & absorbance/manual
Monocytes 5.00 % 2.0-10.0
Method Name: Impedance & absorbance/manual
Basophils 0.00 % <1.0-2.0

DR. UMA SHANKAR DR. ANKIT [Link] KUMAR SINGH

MBBS, MD (PATH) MBBS. MD (PATH) PhD. in Microbiology
Page 1 of 11 CONSULTANT PATHOLOGIST CONSULTANT PATHOLOGIST Consultant Microbiologist
 Name Of Patient : Mrs. SARITA Reg. No : 0012601310166
Age/Gender : 38 Years/Female Collected On : 31-Jan-2026 02:13 PM
Referred By : Dr. SELF Received On : 31-Jan-2026 04:14 PM
Sample Type/ID : EDTA/818766 Reported On : 31-Jan-2026 04:23 PM
Client Panel : DL462-HEALTH X PLUS LABS- Report Status : Final Report
Referred By Lab : Self

HAEMATOLOGY
Test Name Results Unit [Link]
Method Name: Impedance & absorbance/manual
ANC Absolute Neutrophil Count 7.49 10^3/µL 2.0-7.0
Method Name: Calculated
ALC Absolute Lymphocyte Count 2.14 10^3/µL 1.0-3.0
Method Name: Calculated
AEC Absolute Eosinophil Count 0.54 10^3/µL 0.02-0.50
Method Name: Calculated
AMC Absolute Monocyte Count 0.54 10^3/µL 0.20-1.00
Method Name: Calculated
ABC Absolute Basophil Count 0.00 10^3/µL 0.00-0.10
Method Name: Calculated
Interpretation

A complete blood count (CBC) is a blood test used to evaluate overall health and detect a wide range of disorders, including anemia, infection and leukemia.

Detect abnormalities in your blood that may be signs of disease.

Diagnose or monitor many different disorders, conditions and infections.

Evaluate your overall health.

Rule out conditions, disorders and disease.

Monitor various blood diseases.

Note :- The result obtained relate only to the sample given/ received & tested. A single test result is not always indicative of a disease, it must be correlated with
clinical data for interpretation.

*** End Of Report ***

Laboratory is NABL Accredited

DR. UMA SHANKAR DR. ANKIT [Link] KUMAR SINGH

MBBS, MD (PATH) MBBS. MD (PATH) PhD. in Microbiology
Page 2 of 11 CONSULTANT PATHOLOGIST CONSULTANT PATHOLOGIST Consultant Microbiologist
 Name Of Patient : Mrs. SARITA Reg. No : 0012601310166
Age/Gender : 38 Years/Female Collected On : 31-Jan-2026 02:13 PM
Referred By : Dr. SELF Received On : 31-Jan-2026 04:14 PM
Sample Type/ID : Whole Blood EDTA/818766 Reported On : 31-Jan-2026 05:12 PM
Client Panel : DL462-HEALTH X PLUS LABS- Report Status : Final Report
Referred By Lab : Self

HAEMATOLOGY
Test Name Results Unit [Link]

ESR (Erythrocyte Sedimentation Rate)

ESR (Wintrobe Method) 18 mm/1st hr. 0 - 20
Method Name: Wintrobe
CLINICAL COMMENTS

Erythrocyte sedimentation rate (ESR) is a relatively simple, inexpensive, non-specific test that indirectly measures the degree of inflammation present in
the body. Inflammation is part of the body's immune response. It can be acute, developing rapidly after trauma, injury or infection, for example, or can
occur over an extended time (chronic) with conditions such as autoimmune diseases or cancer. Moderately elevated ESR occurs with inflammation but also
with anemia, infection, pregnancy, and with aging. A very high ESR can be seen in severe infection, marked by an increase in globulins, systemic
vasculitis, polymyalgia rheumatica or temporal arteritis. People with multiple myeloma or Waldenstrom's macroglobulinemia (tumors that make large
amounts of immunoglobulins) typically have very high ESRs

Factors Increasing ESR

Advanced age, Anemia,Pregnancy,High fibrinogen,Macrocytosis,Kidney problems,Thyroid disease,Some cancers, such as multiple myeloma,Infection.

Factors Decreasing ESR

Microcytosis,Low fibrinogen,Polycythemia,Marked leukocytosis.

Note :- The result obtained relate only to the sample given/ received & tested. A single test result is not always indicative of a disease, it
has to be correlated with clinical data for interpretation.

*** End Of Report ***

Laboratory is NABL Accredited

DR. UMA SHANKAR DR. ANKIT [Link] KUMAR SINGH

MBBS, MD (PATH) MBBS. MD (PATH) PhD. in Microbiology
Page 3 of 11 CONSULTANT PATHOLOGIST CONSULTANT PATHOLOGIST Consultant Microbiologist
 Name Of Patient : Mrs. SARITA Reg. No : 0012601310166
Age/Gender : 38 Years/Female Collected On : 31-Jan-2026 02:13 PM
Referred By : Dr. SELF Received On : 31-Jan-2026 04:14 PM
Sample Type/ID : EDTA/818766 Reported On : 31-Jan-2026 04:46 PM
Client Panel : DL462-HEALTH X PLUS LABS- Report Status : Final Report
Referred By Lab : Self

HAEMATOLOGY
Test Name Results Unit [Link]

HBA1C (Glycosylated Hemoglobin)

HbA1c (NGSP) 6.40 % <5.7 Non diabetic,
Method Name: HPLC 5.7-6.4 Borderline
diabetic,
>6.4 Diabetic.
Estimated Average Glucose 136.98 mg/dL 90-120 Excellent Control
Method Name: Calculated 121-150 Good control
151-180 Average control
181-210 Action Suggested
>211 Panic Value.
CLINICAL COMMENT

HbA1c is used for monitoring diabetic [Link] reflects the mean plasma glucose over three months.

Trends in HbA1c are a better indicator of diabetic control than a solitary test.

HbA1c target in pregnancy is to attain level <6 % .

HbA1c target in pediatric age group is to attain level < 7.5 %.

REMARKS

1. Shortened RBC life span –HbA1c test will not be accurate when a person has a condition that affects the average lifespan of red blood cells (RBCs), such as
hemolytic anemia or blood loss. When the lifespan of RBCs in circulation is shortened, the A1c result is falsely low and is an unreliable measurement of a
person's average glucose over time.

2. Abnormal forms of hemoglobin – The presence of some hemoglobin variants, such as hemoglobin S in sickle cell anemia, may affect certain methods for
measuring A1c. In these cases, fructosamine can be used to monitor glucose control.

Method Ion-exchange high-performance liquid chromatography (HPLC).

Note :- The result obtained relate only to the sample given/ received & tested. A single test result is not always indicative of a disease, it has
to be correlated with clinical data for interpretation.

*** End Of Report ***

Laboratory is NABL Accredited

DR. UMA SHANKAR DR. ANKIT [Link] KUMAR SINGH

MBBS, MD (PATH) MBBS. MD (PATH) PhD. in Microbiology
Page 4 of 11 CONSULTANT PATHOLOGIST CONSULTANT PATHOLOGIST Consultant Microbiologist
 Name Of Patient : Mrs. SARITA Reg. No : 0012601310166
Age/Gender : 38 Years/Female Collected On : 31-Jan-2026 02:13 PM
Referred By : Dr. SELF Received On : 31-Jan-2026 04:14 PM
Sample Type/ID : Serum/818765 Reported On : 31-Jan-2026 05:06 PM
Client Panel : DL462-HEALTH X PLUS LABS- Report Status : Final Report
Referred By Lab : Self

BIOCHEMISTRY
Test Name Results Unit [Link]

LFT (Liver Function Tests)

BILIRUBIN TOTAL,Serum 0.30 mg/dL 0.2-1.2
Method Name: Malloy-Evelyn Modified
BILIRUBIN (Direct) 0.12 mg/dL 0.0-0.30
Method Name: Malloy- Evelyn modified
BILIRUBIN (Indirect) 0.18 mg/dL 0.2-1.0
Method Name: Calculated
SGOT (AST) ,Serum 11.60 IU/L 0.0-32.0
Method Name: Kinetic UV
SGPT (ALT), Serum 17.10 U/L 5-34
Method Name: Kinetic UV
ALKALINE PHOSPHATASE ,Serum 82.30 U/L 42.0-98.0
Method Name: IFCC-Enzymatic-kinetic
GAMMA G.T. ,Serum 31.40 U/L 5.0-55.0
Method Name: G-glutamyl-p-nitroanili
TOTAL PROTEIN , Serum 6.89 g/dL 6.4-8.3
Method Name: Biuret
ALBUMIN,Serum 4.20 g/dL 3.5-5.2
Method Name: Bromocresol Green (BCG)-colorimetric
Globulin 2.69 g/dL 2.50 - 3.5
Method Name: Calculated
A/G Ratio ,Serum 1.56 Ratio 1.0 - 2.3
Method Name: Calculated
CLINICAL COMMENT
ALT: ALT is a sensitive test for detecting liver injury in hepatitis. People with acute hepatitis often LIhave markedly elevated ALT levels, while those with chronic
hepatitis usually have mild to moderately elevated levels.
AST: AST is present in the liver, heart, and skeletal muscle and is released into the blood when these tissues are damaged.
BILRUBIN: Bilirubin is a yellow pigment formed from the breakdown of hemoglobin, and elevated levels indicate impaired liver function or biliary obstruction.
GGT: GGT is found mainly in the liver and can be used to confirm the source of elevated ALP levels. Both ALP and GGT are elevated in liver or bile duct disease.
ALP: Elevated ALP with abnormal LFTs suggests a hepatic source rather than bone disease.
PROTEIN: Total protein reflects the combined concentration of albumin and globulins, including antibodies.
ALBUMIN: Low serum albumin suggests chronic liver disease or renal protein loss.

Reference ranges are from Teitz fundamental of clinical chemistry 8th ed (2018). Reference ranges vary between laboratories.
NOTES : The result obtained relate only to the sample given/ received & tested. A single test result is not always indicative of a disease, it must be correlated with
clinical data for interpretation.

*** End Of Report ***

Laboratory is NABL Accredited

DR. UMA SHANKAR DR. ANKIT [Link] KUMAR SINGH

MBBS, MD (PATH) MBBS. MD (PATH) PhD. in Microbiology
Page 5 of 11 CONSULTANT PATHOLOGIST CONSULTANT PATHOLOGIST Consultant Microbiologist
 Name Of Patient : Mrs. SARITA Reg. No : 0012601310166
Age/Gender : 38 Years/Female Collected On : 31-Jan-2026 02:13 PM
Referred By : Dr. SELF Received On : 31-Jan-2026 04:14 PM
Sample Type/ID : Serum/818765 Reported On : 31-Jan-2026 05:06 PM
Client Panel : DL462-HEALTH X PLUS LABS- Report Status : Final Report
Referred By Lab : Self

BIOCHEMISTRY
Test Name Results Unit [Link]

KFT (Kidney Function Tests)

UREA,Serum 23.9 mg/dL 17.0 -44.0
Method Name: Enzymatic UV Kinetic (Urease, UV)
CREATININE , Serum 0.60 mg/dl 0.60-1.10
Method Name: Enzymatic kinetic
URIC ACID ,Serum 5.90 mg/dL 2.6 - 6.0
Method Name: Uricase Enzymatic-colorimetric
SODIUM ,Serum 134.5 mmol/L 132-146
Method Name: ISE
POTASSIUM ,Serum 4.08 mmol/L 3.5-5.1
Method Name: ISE
CHLORIDE,Serum 99.50 mmol/L 96-107
Method Name: ISE
BLOOD UREA NITROGEN (BUN),Serum 11.17 mg/dl 6 - 20
Method Name: Urease – UV
BUN/CREATININE RATIO 18.62 Ratio 10-20
Method Name: Calculated
UREA/CREATININE RATIO 39.83 Ratio 20-35
Method Name: Calculated
CALCIUM, Serum 8.50 mg/dL 8.50-10.50
Method Name: Arsenazo III- Colorimetric
Clinical comments

Urea & Creatinine : Increased levels indicates impaired renal function. They may be elevated due to intrinsic kidney disease or due to reduced blood flow to the kidney (pre-renal
causes) or urinary tract obstruction (Post renal causes)
Uric Acid : High uric acid levels occurs when the kidney cannot eliminates it efficiently cause includes a diet high in Purine - rich food, obesity, insulin resistance, a certain
medication ( like diuretics ), and kidney problems .
Electrolytes : kidney disease can disrupt level of electrolytes such as Sodium, Potassium, calcium and phosphate . These imbalance can affect fluid balance and acid base (Ph)
levels in the body.
Calcium- Helps with muscles concentration, nerve signalling, blood clotting, enzymes, activation and maintaining bones and teeth.

Notes : The result obtained relate only to the sample given/ received & tested. A single test result is not always indicative of a disease, it must be correlated with clinical data for
interpretation.

Reference ranges are from Teitz fundamental of clinical chemistry 8th ed (2018).Reference ranges vary between laboratories

*** End Of Report ***

Laboratory is NABL Accredited

DR. UMA SHANKAR DR. ANKIT [Link] KUMAR SINGH

MBBS, MD (PATH) MBBS. MD (PATH) PhD. in Microbiology
Page 6 of 11 CONSULTANT PATHOLOGIST CONSULTANT PATHOLOGIST Consultant Microbiologist
 Name Of Patient : Mrs. SARITA Reg. No : 0012601310166
Age/Gender : 38 Years/Female Collected On : 31-Jan-2026 02:13 PM
Referred By : Dr. SELF Received On : 31-Jan-2026 04:14 PM
Sample Type/ID : PLASMA F/818764 Reported On : 31-Jan-2026 04:59 PM
Client Panel : DL462-HEALTH X PLUS LABS- Report Status : Final Report
Referred By Lab : Self

BIOCHEMISTRY
Test Name Results Unit [Link]

Blood Glucose Fasting

GLUCOSE FASTING 116.60 mg/dL Noraml <100.0
Method Name: Enzymatic-Colorimetric (GOD-PAP) Pre-diabetic 100-125
Diabetic >=126
Comment:-
Conditions that can result in an elevated blood glucose level include: Acromegaly, Acute stress (response to trauma, heart attack, and stroke for
instance),Chronic kidney disease, Cushing syndrome, Excessive consumption of food, Hyperthyroidism, Pancreatitis.A low level of glucose may indicate
hypoglycemia, a condition characterized by a drop in blood glucose to a level where first it causes nervous system symptoms.(sweating, palpitations,
hunger, trembling, and anxiety), then begins to affect the brain (causing confusion, hallucinations, blurred vision, and sometimes even coma and death). A
low blood glucose level (hypoglycemia) may be seen with:Adrenal insufficiency, Drinking excessive alcohol, Severe liver disease,
Hypopituitarism,Hypothyroidism, Severe infections, Severe heart failure, Chronic kidney (renal) failure, Insulin overdose, Tumors that produce insulin
(insulinomas), Starvation.

NOTE-The result obtained relate only to the sample given/ received & tested. A single test result is not always indicative of a disease; it has
to be correlated with clinical data for interpretation.

*** End Of Report ***

Laboratory is NABL Accredited

DR. UMA SHANKAR DR. ANKIT [Link] KUMAR SINGH

MBBS, MD (PATH) MBBS. MD (PATH) PhD. in Microbiology
Page 7 of 11 CONSULTANT PATHOLOGIST CONSULTANT PATHOLOGIST Consultant Microbiologist
 Name Of Patient : Mrs. SARITA Reg. No : 0012601310166
Age/Gender : 38 Years/Female Collected On : 31-Jan-2026 02:13 PM
Referred By : Dr. SELF Received On : 31-Jan-2026 04:14 PM
Sample Type/ID : Serum/818765 Reported On : 31-Jan-2026 05:06 PM
Client Panel : DL462-HEALTH X PLUS LABS- Report Status : Final Report
Referred By Lab : Self

BIOCHEMISTRY
Test Name Results Unit [Link]

Lipid Profile
TOTAL CHOLESTEROL, Serum 170.50 mg/dL Desirable<200
Method Name: Enzymatic-colorimetric (CHOD-PAP) Borderline 200-239
High > 239
TRIGLYCERIDE , Serum 191.20 mg/dL Normal <150
Method Name: Enzymatic (GPO-PAP)-colorimetric Borderline 150-199
High 200-499
Very High >499
HDL-CHOLESTEROL , Serum 54.50 mg/dL >40 Recommended range
Method Name: Direct measure
NON HDL CHOLESTEROL,Serum 116.00 mg/dL <130
Method Name: Calculated
LDL CHOLESTEROL,Serum 77.76 mg/dL Optimal<100
Method Name: Calculated Near or Above Optima-
l00-129
Borderline High 130 - 159
High 160 - 189
Very High >190
VLDL CHOLESTEROL ,Serum 38.24 mg/dL 0.0- 30.0
Method Name: Calculated
TOTAL CHOLESTEROL /HDL RATIO ,Serum 3.13 Ratio low Risk < 3.0
Method Name: Calculated Average Risk3.0-5.0
High Risk > 5.0
LDL / HDL CHOLESTEROL RATIO 1.43 Ratio 1.5-3.5
Method Name: Calculated
HDL/LDL CHOLESTEROL RATIO 0.70 Ratio <3.50
Method Name: Calculated

Fasting: 10–12 hours needed for lipid profile.

Lipemic sample: Too cloudy (high chylomicrons) → repeat after 1 week on a fat-free diet.

Lipids are fats and fat-like substances such as cholesterol, triglycerides, and fatty acids. They provide energy for the body. Lipid levels are important for health. High
cholesterol increases the risk of heart disease and stroke.

There are two types of cholesterol. LDL (bad cholesterol) increases the risk of heart disease. HDL (good cholesterol) helps remove extra cholesterol from the blood.

High levels of triglycerides also increase the risk of heart disease.

Reference ranges are from Teitz fundamental of clinical chemistry 8th ed (2018). Reference ranges vary between laboratories.
NOTES : The result obtained relate only to the sample given/ received & tested. A single test result is not always indicative of a disease, it must be correlated with clinical data for
interpretation.

*** End Of Report ***

Laboratory is NABL Accredited

DR. UMA SHANKAR DR. ANKIT [Link] KUMAR SINGH

MBBS, MD (PATH) MBBS. MD (PATH) PhD. in Microbiology
Page 8 of 11 CONSULTANT PATHOLOGIST CONSULTANT PATHOLOGIST Consultant Microbiologist
 Name Of Patient : Mrs. SARITA Reg. No : 0012601310166
Age/Gender : 38 Years/Female Collected On : 31-Jan-2026 02:13 PM
Referred By : Dr. SELF Received On : 31-Jan-2026 04:14 PM
Sample Type/ID : Serum/818765 Reported On : 31-Jan-2026 05:06 PM
Client Panel : DL462-HEALTH X PLUS LABS- Report Status : Final Report
Referred By Lab : Self

BIOCHEMISTRY
Test Name Results Unit [Link]

Iron Deficiency Profile -1

Iron 57.80 µg/dL 37.0-145.0
Method Name: TPTZ
UIBC 244.10 µg/dL 120.0-347.0
Method Name: NiTRO-PSAP
TOTAL IRON BINDING CAPACITY 301.90 µg/dL 240.0-450.0
Method Name: Calculated
TRANSFERRIN SATURATION 19.15 % 15.0-50.0
Method Name: Calculated

CLINICAL COMMENTS:-
Iron is an essential nutrient that, among other functions, is needed in small quantities to help form normal red blood cells (RBCs).
Serum iron test: measures the level of iron in the liquid portion of the blood.
Transferrin test: directly measures the level of transferrin in the blood. Transferrin is the protein that transports iron around in the body. Under normal
conditions, transferrin is typically one-third saturated with iron. This means that about two-thirds of its capacity is eld in reserve.
TIBC (total iron-binding capacity): measures the total amount of iron that can be bound by proteins in the blood. Since transferrin is the primary iron-
binding protein, the TIBC test is a good indirect measurement of transferrin availability.
UIBC (unsaturated iron-binding capacity): The UIBC test determines the reserve capacity of transferrin, i.e., the portion of transferrin that has not yet
been saturated with iron. UIBC also reflects transferrin levels.
Transferrin saturation: a calculation that reflects the percentage of transferrin that is saturated with iron (100 x serum iron/TIBC).
Serum ferritin: reflects the amount of stored iron in the body.
INCREASED IN:

Hemosiderosis of excessive iron intake (e.g. repeated blood transfusion, iron therapy, iron containing vitamins).
Decreased formation of RBCs (thalassemia, pyridoxal deficiency anaemia).
Increased destruction of RBCs (hemolytic anaemia).
Acute liver damage
Progesteronal birth control pills & pregnancy
Premenstrual elevation
cute iron toxicity

DECREASED IN:

Iron deficiency anaemia

Normochromic anaemia of infections & chronic diseases
Nephrosis -Menstruation
Diurnal variation: Normal in mid morning, low values in mid afternoon, and very low values near midnight.

Note :- The result obtained relate only to the sample given/ received & tested. A single test result is not always indicative of a disease, it has
to be correlated with clinical data for interpretation

*** End Of Report ***

Laboratory is NABL Accredited

DR. UMA SHANKAR DR. ANKIT [Link] KUMAR SINGH

MBBS, MD (PATH) MBBS. MD (PATH) PhD. in Microbiology
Page 9 of 11 CONSULTANT PATHOLOGIST CONSULTANT PATHOLOGIST Consultant Microbiologist
 Name Of Patient : Mrs. SARITA Reg. No : 0012601310166
Age/Gender : 38 Years/Female Collected On : 31-Jan-2026 02:13 PM
Referred By : Dr. SELF Received On : 31-Jan-2026 04:14 PM
Sample Type/ID : Serum/818765 Reported On : 31-Jan-2026 05:06 PM
Client Panel : DL462-HEALTH X PLUS LABS- Report Status : Final Report
Referred By Lab : Self

IMMUNOLOGY
Test Name Results Unit [Link]

Thyroid Function Test (TFT)

T3 (Triiodothyronine) ,Serum 1.32 ng/mL 0.70-2.04
Method Name: Electrohemiluminescence immunoassay (CLIA)
T4 (Thyroxine) ,Serum 8.87 µg/dl 4.60-10.50
Method Name: Electrochemiluminescence immunoassay (CLIA)
Ultrasensitive TSH (Thyroid Stimulating 3.281 µIU/ml 0.40-5.50
Hormone),Serum
Method Name: Chemiluminescence immunoassay (CLIA)

Interpretation:-
TSH is a glycoprotein hormone secreted by the anterior pituitary. TSH is a labile hormone & is secreted in a pulsatile manner throughout the day and is
subject to several non-thyroidal pituitary influences. Significant variations in TSH can occur with circadian rhythm, hormonal status, stress, sleep
deprivation, caloric intake, medication & circulating antibodies.
REFERENCE RANGE in uIU/mL (As per Tietz
REFERENCE GROUP, Pregnancy
Fundamentals of clinical chemistry 7th ed)
1st Trimester 0.30– 4.50
2nd Trimester 0.50 – 4.60
3rd Trimester 0.80 – 5.20
REFERENCE GROUP REFERENCE RANGE in uIU/mL
1-4 days 1.00-39.00
5 days – 20 wks 1.70-9.10
21 wks – 20 years 0.70 – 6.40
Males > 20 years 0.40– 5.50
Adult Females (> 20 years) 0.40– 5.50

Clinical Use
· Diagnose Hypothyroidism and Hyperthyroidism
· Monitor T4 replacement or T4 suppressive therapy
· Quantify TSH levels in the subnormal range.

TSH levels are subject to circadian variation, reaching peak levels between 2-4 AM and min between 6-10 PM. The variation is the order of 50% hence time
of the day has influence on the measures serum TSH concentration. Dose and time of drug intake also influence the test result.

Disclaimer-TSH is an important marker for the diagnosis of thyroid dysfunction. Recent studies have shown that the TSH distribution progressively shifts
to a higher concentration with age ,and it is debatable whether this is due to a real change with age or an increasing proportion of unrecognized thyroid
disease in the elderly.

Reference ranges are from Teitz fundamental of clinical chemistry 7th ed.

NOTE-The result obtained relate only to the sample given/ received & tested. A single test result is not always indicative of a disease; it has
to be correlated with clinical data for interpretation.

*** End Of Report ***

Laboratory is NABL Accredited

DR. UMA SHANKAR DR. ANKIT [Link] KUMAR SINGH

MBBS, MD (PATH) MBBS. MD (PATH) PhD. in Microbiology
Page 10 of 11 CONSULTANT PATHOLOGIST CONSULTANT PATHOLOGIST Consultant Microbiologist
 Name Of Patient : Mrs. SARITA Reg. No : 0012601310166
Age/Gender : 38 Years/Female Collected On : 31-Jan-2026 02:13 PM
Referred By : Dr. SELF Received On : 31-Jan-2026 04:14 PM
Sample Type/ID : Urine/818767 Reported On : 31-Jan-2026 04:51 PM
Client Panel : DL462-HEALTH X PLUS LABS- Report Status : Final Report
Referred By Lab : Self

CLINICAL PATHOLOGY
Test Name Results Unit [Link]

CUE,Complete Urine Examination

PHYSICAL & CHEMICAL EXAMINATION
Volume 30.00 ml

Colour P. Yellow Pale Yellow

Appearance Clear Clear

pH 5.00 5.0-8.0
Method Name: Double indicator
Specific Gravity 1.015 1.003-1.035
Method Name: Refractometric
Protein urine Negative Negative
Method Name: Protein error of indicator
Glucose urine Negative Negative
Method Name: Oxidase Peroxidase Reaction
Ketone Negative Negative
Method Name: Diazo Method
Bilirubin Negative Negative
Method Name: Azo coupling reaction & fouchets
Urobilinogen Normal Normal
Method Name: Modified Ehrlich Reaction
Blood Negative Negative
Method Name: Peroxidase Reaction
Nitrite Negative Negative
Method Name: Diazo Method
Leucocytes Negative Negative
Method Name: Derivatized Phenyl Pyrrole & Diazonium
MICROSCOPIC EXAMINATION (/HPF)
R.B.C Nil /hpf 0-2

Pus cells 1-2 /hpf 0-4

Epithelial cells 2-3 /hpf 0-3

Bacteria Nil

Casts None seen None seen

Crystals None seen None seen

*** End Of Report ***

Laboratory is NABL Accredited

DR. UMA SHANKAR DR. ANKIT [Link] KUMAR SINGH

MBBS, MD (PATH) MBBS. MD (PATH) PhD. in Microbiology
Page 11 of 11 CONSULTANT PATHOLOGIST CONSULTANT PATHOLOGIST Consultant Microbiologist